All In MedTech

Device Trial Radar · NCT03808116

Evaluation of the SmartBx System for Breast Biopsy

Evaluation of the SmartBx System for Breast Biopsy Download While Keeping the Orientation, Unfolding and Unity of the Sample

Last checked: Nov 20, 2026Latest source record: Nov 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jun 10, 2019

Primary completion

Aug 5, 2019

Study completion Sep 1, 2019

Sponsor

Lead sponsor
UC Care, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jan 17, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of: 3\. Biopsy core length obtained (i.e. collecting all tissue fragments) 4. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)

Conditions

  • Breast Cancer

Interventions

  • SmartBxDevice

    he SmartBx device is intended for the retention of a biopsy specimen and for preservation of the specimen's in-needle location and orientation. The SmartBx is used as an aiding tool in biopsy procedures. When operated in conjunction with the standard equipment in a prostate biopsy procedure, the SmartBx may be used for the following: * To preserve sample unity, including core fragments in their original location along the needle notch. * Avoid sample damaging during sample removal from the needle and the following pathology process.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. biopsy core lengthTime frame: 1 month
  2. biopsy core yieldTime frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Haemek medical center

    Afula, North Region, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.